お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
988052

体外診断の世界市場:製品別、アプリケーション別、技術別(免疫化学、分子診断)、最終用途別、地域別の市場規模、シェアおよび動向分析、セグメント別予測(2021年~2027年)

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics), By End-use, By Region, And Segment Forecasts, 2021 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 200 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.46円
体外診断の世界市場:製品別、アプリケーション別、技術別(免疫化学、分子診断)、最終用途別、地域別の市場規模、シェアおよび動向分析、セグメント別予測(2021年~2027年)
出版日: 2021年01月19日
発行: Grand View Research, Inc.
ページ情報: 英文 200 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の体外診断(IVD)の市場規模は、2021年から2027年にかけて4.5%のCAGRで拡大し、2027年までに1,139億米ドルに達すると予想されています。高齢者人口の増加と、その採用を支えている診断技術の進歩が市場成長を促進する主な要因となっています。

精度、可搬性、費用対効果の面での技術進歩は、この市場を成長させている主な要因となる見通しです。たとえば、2017年6月、Agena Bioscienceは、欧州でCHIP PrepModuleと統合されたMassARRAYシステムを発売しました。このシステムは、体外診断用医療機器指令(Directive 98/79/EC)に基づいてCE-IVD製品として販売されました。さらに、リアルタイムポリメラーゼ連鎖反応(qPCR)は、体外診断(IVD)市場で最も急成長しているアプリケーションセグメントの1つです。

当レポートでは、世界の体外診断(IVD)市場について調査分析し、市場および業界の見通し、セグメント別・地域別の見通しのほか、競合情勢について、体系的な情報を提供しています。

目次

第1章 調査方法と範囲

第2章 市場の定義

第3章 エグゼクティブサマリー

第4章 世界のIVD市場の変数、動向、範囲

  • IVD市場系統の見通し
  • 浸透と成長の見通しのマッピング
  • 規制の枠組み
  • 市場抑制要因分析
  • 要因別のSWOT分析(政治的および法的、経済的、および技術的)
  • ポーターのファイブフォース分析
  • 主要な取引と戦略的提携の分析

第5章 IVD市場-セグメント分析、製品別、2016年~2027年(百万米ドル)

  • 体外診断市場:製品別市場の動向分析
  • 器具
  • 試薬
  • サービス

第6章 IVD市場-セグメント分析、技術別、2016年~2027年(百万米ドル)

  • 体外診断市場:技術別動向分析
  • イムノアッセイ
    • 器具
    • 試薬
    • サービス
  • 血液学
    • 器具
    • 試薬
    • サービス
  • 臨床化学
    • 器具
    • 試薬
    • サービス
  • 分子診断
    • 器具
    • 試薬
    • サービス
  • 凝固
    • 器具
    • 試薬
    • サービス
  • 微生物学
    • 器具
    • 試薬
    • サービス
  • その他
    • 器具
    • 試薬
    • サービス

第7章 IVD市場-セグメント分析、アプリケーション別、2016年~2027年(百万米ドル)

  • In Vitro診断市場:アプリケーション別市場の動向分析
  • 感染症
  • 糖尿病
  • 腫瘍学
  • 心臓病学
  • 腎臓学
  • 自己免疫疾患
  • 薬物検査
  • その他

第8章 IVD市場-セグメント分析、最終用途別、2016年~2027年(百万米ドル)

  • 体外診断市場:最終用途別市場の動向分析
  • 病院
  • 研究室
  • 在宅医療
  • その他

第9章 IVD市場-セグメント分析、地域別、2016年~2027年(百万米ドル)

  • 体外診断市場:地域別市場の動向分析
  • 北米
    • 北米、 SWOT分析
    • 米国
  • カナダ
  • 欧州
    • 欧州、 SWOT分析
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • ロシア
  • アジア太平洋
    • アジア太平洋、 SWOT分析
    • 日本
    • 中国
    • インド
    • 韓国
    • シンガポール
    • オーストラリア
  • ラテンアメリカ
    • ラテンアメリカ、 SWOT分析
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ、 SWOT分析
    • 南アフリカ
    • アラブ首長国連邦
    • サウジアラビア

第10章 競合分析

  • 主要な市場参加者別最新動向と影響分析
    • Ansoffマトリックス
    • 企業/競合の分類(主要なイノベーター、マーケットリーダー、拡大)
    • イノベーター
  • ベンダー情勢
    • 主要なディストリビューターとチャネルパートナーのリスト
  • 質量分析
  • イムノアッセイ
  • PCR
  • 公開企業
    • 企業の市況分析
    • 競合のダッシュボード分析
    • 戦略的フレームワーク
  • 非公開企業
    • 主要な新興企業/テクノロジーディスラプター/イノベーターのリスト
    • 地域ネットワークマップ
  • 企業プロファイル
    • Abbott
    • bioMerieux SA
    • Bio-Rad Laboratories、Inc。
    • Becton、Dickinson and Company
    • Siemens Healthineers AG
    • Qiagen
    • Quidel Corporation
    • F. Hoffmann-La Roche AG
    • Sysmex Corporation
    • Charles River Laboratories International, Inc
    • Quest Diagnostics
    • Agilent Technologies
    • Danaher Corporation
図表

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global In Vitro Diagnostics Product Market, By Region, 2016 - 2027 (USD Million)
  • TABLE 5 Global In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 6 Global In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 7 Global In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 8 Global In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 9 North America In Vitro Diagnostics Product Market, By Country, 2016 - 2027 (USD Million)
  • TABLE 10 North America In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 11 North America In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 12 North America In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 13 North America In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 14 U.S. In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 15 U.S. In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 16 U.S. In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 17 U.S. In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 18 Canada In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 19 Canada In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 20 Canada In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 21 Canada In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 22 Europe In Vitro Diagnostics Product Market, By Country, 2016 - 2027 (USD Million)
  • TABLE 23 Europe In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 24 Europe In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 25 Europe In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 26 Europe In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 27 U.K. In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 28 U.K. In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 29 U.K. In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 30 U.K. In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 31 Germany In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 32 Germany In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 33 Germany In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 34 Germany America In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 35 France In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 36 France In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 37 France In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 38 France In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 39 Spain In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 40 Spain In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 41 Spain In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 42 Spain In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 43 Italy In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 44 Italy In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 45 Italy In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 46 Italy In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 47 Russia In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 48 Russia In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 49 Russia In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 50 Russia In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 51 Asia Pacific In Vitro Diagnostics Product Market, By Country, 2016 - 2027 (USD Million)
  • TABLE 52 Asia Pacific In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 53 Asia Pacific In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 54 Asia Pacific In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 55 Asia Pacific In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 56 China In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 57 China In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 58 China In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 59 China In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 60 Japan In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 61 Japan In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 62 Japan In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 63 Japan In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 64 India In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 65 India In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 66 India In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 67 India In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 68 South Korea In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 69 South Korea In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 70 South Korea In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 71 South Korea In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 72 Singapore In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 73 Singapore In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 74 Singapore In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 75 Singapore In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 76 Australia In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 77 Australia In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 78 Australia In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 79 Australia In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 80 Latin America In Vitro Diagnostics Product Market, By Country, 2016 - 2027 (USD Million)
  • TABLE 81 Latin America In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 82 Latin America In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 83 Latin America In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 84 Latin America In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 85 Brazil In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 86 Brazil In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 87 Brazil In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 88 Brazil In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 89 Mexico In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 90 Mexico In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 91 Mexico In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 92 Mexico In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 93 Argentina In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 94 Argentina In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 95 Argentina In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 96 Argentina In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 97 MEA In Vitro Diagnostics Product Market, By Country, 2016 - 2027 (USD Million)
  • TABLE 98 MEA In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 99 MEA In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 100 MEA In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 101 MEA In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 102 South Africa In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 103 South Africa In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 104 South Africa In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 105 South Africa In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 106 UAE In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 107 UAE In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 108 UAE In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 109 UAE In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
  • TABLE 110 Saudi Arabia In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 111 Saudi Arabia In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
  • TABLE 112 Saudi Arabia In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
  • TABLE 113 Saudi Arabia In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 In Vitro Diagnostics Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 In vitro diagnostic market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 In vitro diagnostic market driver impact
  • Fig. 13 Global population by age group, 2016 & 2027
  • Fig. 14 In vitro diagnostic market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Porter's Five Forces Analysis
  • Fig. 17 Strategy mapping
  • Fig. 18 IVD market: Products outlook and key takeaways
  • Fig. 19 IVD market: Products movement analysis
  • Fig. 20 Instruments market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 21 Reagents market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 22 Services market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 23 IVD market: Technology outlook and key takeaways
  • Fig. 24 IVD Market: Technology Movement Analysis
  • Fig. 25 Immunoassay market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 26 Instruments market for immunoassay estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 27 Reagents market for immunoassay estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 28 Services market for immunoassay estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 29 Hematology market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 30 Instruments market for hematology estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 31 Reagents market for hematology estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 32 Services market for hematology estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 33 Clinical chemistry market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 34 Instruments market for clinical chemistry estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 35 Reagents market for clinical chemistry estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 36 Services market for clinical chemistry estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 37 Molecular diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 38 Instruments market for molecular diagnostics estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 39 Reagents market for molecular diagnostics estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 40 Services market for molecular diagnostics estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 41 Coagulation market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 42 Instruments market for coagulation estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 43 Reagents market for coagulation estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 44 Services market for coagulation estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 45 Microbiology market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 46 Instruments market for microbiology estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 47 Reagents market for microbiology estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 48 Services market for microbiology estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 49 Others market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 50 Instruments others market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 51 Reagents others market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 52 Services market for other technology estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 53 IVD market: Application outlook and key takeaways
  • Fig. 54 IVD market: Application movement analysis
  • Fig. 55 Infectious diseases market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 56 Diabetes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 57 Oncology market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 58 Cardiology market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 59 Nephrology market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 60 Autoimmune diseases market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 61 Drug testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 62 Others market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 63 IVD market: End-use outlook and key takeaways
  • Fig. 64 IVD treatment market: End-use movement analysis
  • Fig. 65 Hospitals market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 66 Laboratory market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 67 Home care market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 68 Other market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 69 IVD Market: Regional Outlook and Key Takeaways
  • Fig. 70 IVD market: Regional movement analysis
  • Fig. 71 North America
  • Fig. 72 North America, SWOT
  • Fig. 73 North America market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 74 U.S.
  • Fig. 75 U.S. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 76 Canada
  • Fig. 77 Canada market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 78 Europe
  • Fig. 79 Europe, SWOT
  • Fig. 80 Europe market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 81 U.K.
  • Fig. 82 U.K. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 83 Germany
  • Fig. 84 Germany market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 85 Spain
  • Fig. 86 Spain market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 87 France
  • Fig. 88 France market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 89 Italy
  • Fig. 90 Italy market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 91 Russia
  • Fig. 92 Russia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 93 Asia Pacific
  • Fig. 94 Asia Pacific, SWOT
  • Fig. 95 Asia Pacific market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 96 Japan
  • Fig. 97 Japan market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 98 China
  • Fig. 99 China market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 100 India
  • Fig. 101 India market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 102 South Korea
  • Fig. 103 South Korea market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 104 Singapore
  • Fig. 105 Singapore market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 106 Australia
  • Fig. 107 Australia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 108 Latin America
  • Fig. 109 Latin America, SWOT
  • Fig. 110 Latin America market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 111 Brazil
  • Fig. 112 Brazil market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 113 Mexico
  • Fig. 114 Mexico market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 115 Argentina
  • Fig. 116 Argentina market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 117 Middle East & Africa
  • Fig. 118 Middle East & Africa, SWOT
  • Fig. 119 MEA market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 120 South Africa
  • Fig. 121 South Africa market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 122 United Arab Emirates
  • Fig. 123 United Arab Emirates market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 124 Saudi Arabia
  • Fig. 125 Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 126 Ansoff matrix
  • Fig. 127 Competition categorization
  • Fig. 128 Company market share analysis
  • Fig. 129 Global mass spectrometry company market share analysis
  • Fig. 130 North America mass spectrometry company market share analysis
  • Fig. 131 Europe mass spectrometry company market share analysis
  • Fig. 132 Asia Pacific mass spectrometry company market share analysis
  • Fig. 133 Global immunoassay company market share analysis
  • Fig. 134 North America immunoassay company market share analysis
  • Fig. 135 Europe immunoassay company market share analysis
  • Fig. 136 Asia Pacific immunoassay company market share analysis
  • Fig. 137 Global PCR company market share analysis
  • Fig. 138 North America PCR company market share analysis
  • Fig. 139 Europe PCR company market share analysis
  • Fig. 140 Asia Pacific PCR company market share analysis
  • Fig. 141 Company market position analysis
  • Fig. 142 Company market position analysis
  • Fig. 143 Company market position analysis
  • Fig. 144 Company profiles
  • Fig. 145 Regional Network Map
目次
Product Code: 978-1-68038-080-4

In Vitro Diagnostics Market Growth & Trends

The global in vitro diagnostics market size is expected to reach USD 113.9 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.5% from 2021 to 2027. The growth is driven by the growing geriatric population and technological advancements in diagnostics that are supporting its adoption.

Technological advancements in terms of accuracy, portability, and cost-effectiveness are expected to be one of the high impact rendering drivers of this market. For instance, in June 2017, Agena Bioscience launched the MassARRAY system integrated with CHIP Prep Module in Europe. The system was marketed as a CE-IVD product under Directive 98/79/EC. Moreover, Real-Time Polymerase Chain Reaction (qPCR) is one of the fastest-growing application segments of the in vitro diagnostics (IVD) market.

The IVD market is highly competitive in nature. Consequently, manufacturers are required to improvise products in terms of specificity, accuracy, precision, speed, and other parameters, in order to gain an advantage over previously marketed products.

A steady rise in consumer awareness about diagnosing infectious diseases and increasing disease prevalence, especially in developing and under-developed countries, are driving the market penetration of the products. For instance, in February 2019, Abbott received CE Mark for DETERMINE HBSAG 2 test for detection and diagnosis of hepatitis B surface antigen.

Organizations promote funding to support R&D and product development exercises pertaining to clinical diagnostics. For instance, Vela Diagnostics received USD 225,000 as Biomedical Advanced Research and Development Authority (BARDA) fund to develop COVID-19 tests. Moreover, the introduction of the American Health Care Act of 2017 is expected to improve the healthcare of the U.S. Rising government initiatives pertaining to the importance of IVD will fuel market growth.

The presence of effective technologies such as molecular diagnostics is expected to reduce the threat of substitutes. Moreover, their contribution in the field of genetic testing is of paramount importance and, therefore, experience a low threat of substitutes. However, high prices of these tests are expected to encourage patients to shift to external substitutes.

Major players in the market are Roche Diagnostics; Becton Dickinson; Abbott Laboratories; Siemens; and bioMerieux, which are well-established. Therefore, local companies and new organizations have little scope to enter the market and ensure sustainability. However, companies such as Danaher Corporation and Hologic have successfully excelled in the market through mergers and acquisitions. The seed capital required is high.

In Vitro Diagnostics Market Report Highlights

Molecular diagnostics is expected to witness the fastest growth over the forecast period

High use of reagents in IVD testing, high demand for over-the-counter diagnostic tests, and increase in adoption of these tests in nonmedical facilities, such as home, are some of the factors that are driving the growth, providing it a clinical advantage over other IVD tests

Reagents held the largest market share in 2020 owing to the increasing demand for genetic testing and availability of technologically advanced cancer diagnostic tests in countries with unmet clinical needs, such as India and Middle East & Africa

The growing availability of CE-IVD certified kits globally to diagnose and screen patients during epidemic situations is expected to boost the growth of reagents and instruments segments

Key players are updating their range of testing options for qPCR instruments by undertaking R&D initiatives for the development of kits that target emerging diseases, or by entering into agreements with other kit manufacturing companies

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List of Abbreviations

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Summary

Chapter 4 Global IVD Market Variables, Trends & Scope

  • 4.1 IVD Market Lineage Outlook
    • 4.1.1 Parent Market outlook
  • 4.2 Penetration and Growth Prospect Mapping
  • 4.3 Regulatory Framework
    • 4.3.1 Market Driver Analysis
    • 4.3.2 Growing geriatric population
    • 4.3.3 Technological advancements
    • 4.3.4 Increasing demand for POC facilities
    • 4.3.5 Growing prevalence of target diseases, such as genetic, cardiovascular, and neurological diseases, and hospital-acquired infections
    • 4.3.6 Outbreak of COVID-19
  • 4.4 Market Restraint Analysis
    • 4.4.1 Higher cost of devices
    • 4.4.2 Stringent regulatory policies
  • 4.5 SWOT Analysis, by factor (Political & Legal, Economic, and Technological)
  • 4.6 Porter's Five Forces Analysis
  • 4.7 Major deals and strategic alliances analysis
    • 4.7.1 New product launch
    • 4.7.2 Mergers and acquisitions
    • 4.7.3 Expansion
    • 4.7.4 Partnerships
    • 4.7.5 Marketing & promotions
    • 4.7.6 Market entry strategies
    • 4.7.7 Mergers and Deals

Chapter 5 IVD Market - Segment Analysis, by Product, 2016 - 2027 (USD Million)

  • 5.1 In Vitro Diagnostic Market: Products Movement Analysis
  • 5.2 Instruments
    • 5.2.1 Instruments market estimates and forecast, 2016 - 2027 (USD Million)
  • 5.3 Reagents
    • 5.3.1 Reagents market estimates and forecast, 2016 - 2027 (USD Million)
  • 5.4 Services
    • 5.4.1 Services market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 6 IVD Market - Segment Analysis, by Technology, 2016 - 2027 (USD Million)

  • 6.1 In Vitro Diagnostics Market: Technology Movement Analysis
  • 6.2 Immunoassay
    • 6.2.1 Immunoassay market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.2.2 Instruments
      • 6.2.2.1 Instruments market for immunoassay estimates and forecast, 2016 - 2027 (USD Million)
    • 6.2.3 Reagents
      • 6.2.3.1 Reagents market for immunoassay estimates and forecast, 2016 - 2027 (USD Million)
    • 6.2.4 Services
      • 6.2.4.1 Services market for immunoassay estimates and forecast, 2016 - 2027 (USD Million)
  • 6.3 Hematology
    • 6.3.1 Hematology market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.3.2 Instruments
      • 6.3.2.1 Instruments market for hematology estimates and forecast, 2016 - 2027 (USD Million)
    • 6.3.3 Reagents
      • 6.3.3.1 Reagents market for hematology estimates and forecast, 2016 - 2027 (USD Million)
    • 6.3.4 Services
      • 6.3.4.1 Services market for hematology estimates and forecast, 2016 - 2027 (USD Million)
  • 6.4 Clinical Chemistry
    • 6.4.1 Clinical Chemistry market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.4.2 Instruments
      • 6.4.2.1 Instruments market for clinical chemistry estimates and forecast, 2016 - 2027 (USD Million)
    • 6.4.3 Reagents
      • 6.4.3.1 Reagents market for clinical chemistry estimates and forecast, 2016 - 2027 (USD Million)
    • 6.4.4 Services
      • 6.4.4.1 Services market for clinical chemistry estimates and forecast, 2016 - 2027 (USD Million)
  • 6.5 Molecular Diagnostics
    • 6.5.1 Moecular diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.5.2 Instruments
      • 6.5.2.1 Instruments market for molecular diagnostics estimates and forecast, 2016 - 2027 (USD Million)
    • 6.5.3 Reagents
      • 6.5.3.1 Reagents market for molecular diagnostics estimates and forecast, 2016 - 2027 (USD Million)
    • 6.5.4 Services
      • 6.5.4.1 Services market for molecular diagnostics estimates and forecast, 2016 - 2027 (USD Million)
  • 6.6 Coagulation
    • 6.6.1 Coagulation market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.6.2 Instruments
      • 6.6.2.1 Instruments market for coagulation estimates and forecast, 2016 - 2027 (USD Million)
    • 6.6.3 Reagents
      • 6.6.3.1 Reagents market for coagulation estimates and forecast, 2016 - 2027 (USD Million)
    • 6.6.4 Services
      • 6.6.4.1 Services market for coagulation estimates and forecast, 2016 - 2027 (USD Million)
  • 6.7 Microbiology
    • 6.7.1 Microbiology market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.7.2 Instruments
      • 6.7.2.1 Instruments market for microbiology estimates and forecast, 2016 - 2027 (USD Million)
    • 6.7.3 Reagents
      • 6.7.3.1 Reagents market for microbiology estimates and forecast, 2016 - 2027 (USD Million)
    • 6.7.4 Services
      • 6.7.4.1 Services market for microbiology estimates and forecast, 2016 - 2027 (USD Million)
  • 6.8 Others
    • 6.8.1 Others market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.8.2 Instruments
      • 6.8.2.1 Instruments Others market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.8.3 Reagents
      • 6.8.3.1 Reagents market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.8.4 Services
      • 6.8.4.1 Services market for other technology estimates and forecast, 2016 - 2027 (USD Million)

Chapter 7 IVD Market - Segment Analysis, by Application, 2016 - 2027 (USD Million)

  • 7.1 In Vitro Diagnostic Market: Application Movement Analysis
  • 7.2 Infectious Diseases
    • 7.2.1 Infectious diseases market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.3 Diabetes
    • 7.3.1 Diabetes market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.4 Oncology
    • 7.4.1 Oncology market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.5 Cardiology
    • 7.5.1 Cardiology market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.6 Nephrology
    • 7.6.1 Nephrology market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.7 Autoimmune Diseases
    • 7.7.1 Autoimmune diseases market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.8 Drug Testing
    • 7.8.1 Drug testing market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.9 Others
    • 7.9.1 Others market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 8 IVD Market - Segment Analysis, by End Use, 2016 - 2027 (USD Million)

  • 8.1 In Vitro Diagnostic Market: End-use Movement Analysis
  • 8.2 Hospitals
    • 8.2.1 Hospitals market estimates and forecast, 2016 - 2027 (USD Million)
  • 8.3 Laboratory
    • 8.3.1 Laboratory market estimates and forecast, 2016 - 2027 (USD Million)
  • 8.4 Home Care
    • 8.4.1 Home care market estimates and forecast, 2016 - 2027 (USD Million)
  • 8.5 Others
    • 8.5.1 Other market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 9 IVD Market - Segment Analysis, by Region, 2016 - 2027 (USD Million)

  • 9.1 In Vitro Diagnostic Market: Regional Movement Analysis
  • 9.2 North America
    • 9.2.1 North America, SWOT Analysis
    • 9.2.2 North America market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.2.3 U.S.
      • 9.2.3.1 U.S. market estimates and forecast, 2016 - 2027 (USD Million)
  • 9.3 Canada
    • 9.3.1 Canada market estimates and forecast, 2016 - 2027 (USD Million)
  • 9.4 Europe
    • 9.4.1 Europe, SWOT Analysis
    • 9.4.2 Europe market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.4.3 U.K.
      • 9.4.3.1 U.K. market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.4.4 Germany
      • 9.4.4.1 Germany market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.4.5 Spain
      • 9.4.5.1 Spain market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.4.6 France
      • 9.4.6.1 France market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.4.7 Italy
      • 9.4.7.1 Italy market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.4.8 Russia
      • 9.4.8.1 Russia market estimates and forecast, 2016 - 2027 (USD Million)
  • 9.5 Asia Pacific
    • 9.5.1 Asia Pacific, SWOT Analysis
    • 9.5.2 Asia Pacific market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.5.3 Japan
      • 9.5.3.1 Japan market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.5.4 China
      • 9.5.4.1 China market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.5.5 India
      • 9.5.5.1 India market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.5.6 South Korea
      • 9.5.6.1 South Korea market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.5.7 Singapore
      • 9.5.7.1 Singapore market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.5.8 Australia
      • 9.5.8.1 Australia market estimates and forecast, 2016 - 2027 (USD Million)
  • 9.6 Latin America
    • 9.6.1 Latin America, SWOT Analysis
    • 9.6.2 Latin America market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.6.3 Brazil
      • 9.6.3.1 Brazil market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.6.4 Mexico
      • 9.6.4.1 Mexico market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.6.5 Argentina
      • 9.6.5.1 Argentina market estimates and forecast, 2016 - 2027 (USD Million)
  • 9.7 Middle East and Africa
    • 9.7.1 Middle East & Africa, SWOT Analysis
    • 9.7.2 Middle-East and Africa market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.7.3 South Africa
      • 9.7.3.1 South Africa market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.7.4 United Arab Emirates
      • 9.7.4.1 United Arab Emirates market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.7.5 Saudi Arabia
      • 9.7.5.1 Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 10 Competitive Analysis

  • 10.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 10.1.1 Ansoff matrix
    • 10.1.2 Company/Competition Categorization (Key innovators, Market leaders, Expansion)
    • 10.1.3 Innovators
  • 10.2 Vendor Landscape
    • 10.2.1 List of key distributors and channel partners
    • 10.2.2 Key company market share analysis, 2020
  • 10.3 Mass Spectrometry
    • 10.3.1 Global mass spectrometry company market share analysis, 2020
    • 10.3.2 North America mass spectrometry company market share analysis, 2020
    • 10.3.3 Europe mass spectrometry company market share analysis, 2020
    • 10.3.4 Asia Pacific mass spectrometry company market share analysis, 2020
  • 10.4 Immunoassay
    • 10.4.1 Global immunoassay company market share analysis, 2020
    • 10.4.2 North America immunoassay company market share analysis, 2020
    • 10.4.3 Europe immunoassay company market share analysis, 2020
    • 10.4.4 Asia Pacific immunoassay company market share analysis, 2020
  • 10.5 PCR
    • 10.5.1 Global PCR company market share analysis, 2020
    • 10.5.2 North America PCR company market share analysis, 2020
    • 10.5.3 Europe PCR company market share analysis, 2020
    • 10.5.4 Asia Pacific PCR company market share analysis, 2020
  • 10.6 Public Companies
    • 10.6.1 Company market position analysis
    • 10.6.2 Competitive Dashboard Analysis
    • 10.6.3 Strategic FramewoRk
  • 10.7 Private Companies
    • 10.7.1 List of key emerging companies /technology disruptors/innovators
    • 10.7.2 Regional network map
  • 10.8 Company Profiles
    • 10.8.1 Abbott
      • 10.8.1.1 Company overview
      • 10.8.1.2 Financial performance
      • 10.8.1.3 Product benchmarking
      • 10.8.1.4 Strategic initiatives
    • 10.8.2 bioMerieux SA
      • 10.8.2.1 Company overview
      • 10.8.2.2 Financial Performance
      • 10.8.2.3 Product benchmarking
      • 10.8.2.4 Strategic initiatives
    • 10.8.3 Bio-Rad Laboratories, Inc.
      • 10.8.3.1 Company overview
      • 10.8.3.2 Financial Performance
      • 10.8.3.3 Product benchmarking
      • 10.8.3.4 Strategic initiatives
    • 10.8.4 Becton, Dickinson and Company
      • 10.8.4.1 Company overview
      • 10.8.4.2 Financial performance
      • 10.8.4.3 Product benchmarking
      • 10.8.4.4 Strategic initiatives
    • 10.8.5 Siemens Healthineers AG
      • 10.8.5.1 Company overview
      • 10.8.5.2 Financial Performance
      • 10.8.5.3 Product benchmarking
      • 10.8.5.4 Strategic initiatives
    • 10.8.6 Qiagen
      • 10.8.6.1 Company overview
      • 10.8.6.2 Financial performance
      • 10.8.6.3 Product benchmarking
      • 10.8.6.4 Strategic initiatives
    • 10.8.7 Quidel Corporation
      • 10.8.7.1 Company overview
      • 10.8.7.2 Financial performance
      • 10.8.7.3 Product benchmarking
      • 10.8.7.4 Strategic initiatives
    • 10.8.8 F. Hoffmann-La Roche AG
      • 10.8.8.1 Company overview
      • 10.8.8.2 Financial performance
      • 10.8.8.3 Product benchmarking
      • 10.8.8.4 Strategic initiatives
    • 10.8.9 Sysmex Corporation
      • 10.8.9.1 Company overview
      • 10.8.9.2 Financial performance
      • 10.8.9.3 Product benchmarking
      • 10.8.9.4 Strategic initiatives
    • 10.8.10 Charles River Laboratories International, Inc
      • 10.8.10.1 Company overview
      • 10.8.10.2 Financial performance
      • 10.8.10.3 Product benchmarking
      • 10.8.10.4 Strategic initiatives
    • 10.8.11 Quest Diagnostics
      • 10.8.11.1 Company overview
      • 10.8.11.2 Financial performance
      • 10.8.11.3 Product benchmarking
      • 10.8.11.4 Strategic initiatives
    • 10.8.12 Agilent Technologies
      • 10.8.12.1 Company overview
      • 10.8.12.2 Financial performance
      • 10.8.12.3 Product benchmarking
      • 10.8.12.4 Strategic initiatives
    • 10.8.13 Danaher Corporation
      • 10.8.13.1 Company overview
      • 10.8.13.2 Financial performance
      • 10.8.13.3 Product benchmarking
      • 10.8.13.4 Strategic initiatives
      • 10.8.13.5 Strategic initiatives- Beckman Coulter, Inc.
      • 10.8.13.6 Strategic initiatives- Leica Biosystems
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.